Oncocyte Corporation - Common Shares, No Par Value (OCX)

Historical Holders from Q4 2015 to Q4 2024

Symbol
OCX on Nasdaq
CUSIP
68235C107
Type / Class
Equity / Common Shares, No Par Value
Shares outstanding
28.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
47.1K
Holdings value
$112K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
1
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oncocyte Corporation - Common Shares, No Par Value (OCX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIO-RAD LABORATORIES, INC. 9.7% $6.58M 2.76M BIO-RAD LABORATORIES, INC Feb 10, 2025
SMITH PATRICK W 10.5% $4.22M 1.77M Patrick W. Smith Dec 26, 2024

Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 47.1K $112K -$29.2K $2.38 1
2024 Q3 59.4K $169K -$3.22M $2.85 1
2024 Q2 1.15M $3.4M +$1.01M $2.95 2
2024 Q1 810K $2.37M -$46.2K $2.93 2
2023 Q4 826K $2.05M -$20.4K $2.49 2
2023 Q3 834K $2.72M -$68.4M $3.20 2
2023 Q2 91.8M $21.1M +$8.24M $0.23 45
2023 Q1 55.7M $19.7M -$1.79M $0.35 51
2022 Q4 60.7M $19.5M -$2.59M $0.32 53
2022 Q3 66.1M $48.3M -$1.94M $0.73 53
2022 Q2 66.2M $59.5M +$14.5M $0.90 60
2022 Q1 54.3M $81M -$2.24M $1.49 73
2021 Q4 55.3M $120M -$4.92M $2.17 81
2021 Q3 56.5M $202M -$4.56M $3.56 92
2021 Q2 56.6M $325M +$10.1M $5.74 88
2021 Q1 54.5M $283M +$108M $5.19 83
2020 Q4 30.1M $72M +$2.78M $2.39 55
2020 Q3 31.2M $43.4M -$4.51M $1.39 53
2020 Q2 31M $59.3M +$8.52M $1.91 53
2020 Q1 26.1M $64M +$4.12M $2.45 49
2019 Q4 25.8M $58M +$15.5M $2.25 49
2019 Q3 18.8M $39.5M +$5.93M $2.10 50
2019 Q2 16M $39.7M -$2.95M $2.49 46
2019 Q1 16.1M $63.7M +$30.8M $3.95 44
2018 Q4 8.32M $11.5M -$815K $1.38 14
2018 Q3 8.72M $21.8M -$155K $2.50 19
2018 Q2 8.78M $22.4M +$411K $2.55 23
2018 Q1 8.63M $18.1M +$8.21M $2.10 26
2017 Q4 4.67M $21.7M +$1.17M $4.65 30
2017 Q3 4.41M $33.3M +$3.97M $7.55 24
2017 Q2 3.9M $20.3M +$545K $5.19 28
2017 Q1 3.77M $22.5M +$4.36M $5.95 24
2016 Q4 3.13M $22M +$343K $7.05 25
2016 Q3 3.08M $15.5M +$7.6M $5.04 17
2016 Q2 1.58M $5.62M -$382K $3.56 22
2016 Q1 1.66M $7.66M +$2.62M $4.61 28
2015 Q4 206 $1K +$1K $4.85 1